DC
| |
DAFNA Capital Management LLC13F | |
| DAFNA Capital Management LLC | |
| Last update 2025-05-15 | 82 Stocks (8 new) |
| Value $348.00 Mil | Turnover 8 % |
DAFNA Capital Management LLC Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XBI | SPDR Biotech ETF | 404,505 | 32,805.4 | +1.76% | 9.430 | +0.16% | 0.640 | +15.52% | -3.13% | 5,120.1 | ||
STXS | Stereotaxis Inc | 13,680,554 | 24,077.8 | 0% | 6.920 | 0% | 15.910 | +28.02% | +2.19% | 200.4 | Medical Devices & Instruments | |
RVMD | Revolution Medicines Inc | 656,176 | 23,202.4 | +3.96% | 6.670 | +0.25% | 0.350 | +7.30% | -10.31% | 7,307.3 | Biotechnology | |
MRUS | Merus NV | 461,804 | 19,437.3 | +2.21% | 5.590 | +0.12% | 0.670 | +47.15% | +51.28% | 4,737.8 | Biotechnology | |
ATRC | AtriCure Inc | 592,273 | 19,106.7 | -7.70% | 5.490 | -0.39% | 1.200 | -6.52% | -2.91% | 1,468.8 | Medical Devices & Instruments | |
CYTK | Cytokinetics Inc | 398,100 | 15,999.6 | 0% | 4.600 | 0% | 0.330 | +0.26% | -19.15% | 4,541.8 | Biotechnology | |
BPMC | Blueprint Medicines Corp | 152,263 | 13,476.8 | +1.67% | 3.870 | +0.06% | 0.240 | +52.86% | +48.43% | 8,360.8 | Biotechnology | |
IBB | iShares Biotechnology ETF | 102,500 | 13,109.8 | 0% | 3.770 | 0% | 0.240 | +11.19% | -1.31% | 5,448.9 | ||
AXGN | Axogen Inc | 680,782 | 12,594.5 | -19.61% | 3.620 | -0.70% | 1.490 | -23.72% | -29.73% | 527.4 | Medical Devices & Instruments | |
ASND | Ascendis Pharma AS | 80,398 | 12,530.8 | -22.21% | 3.600 | -0.81% | 0.130 | +5.00% | +22.91% | 10,235.5 | Biotechnology |
DAFNA Capital Management LLC's Historical Top Holdings Breakdowns
DAFNA Capital Management LLC's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
RCUS | Arcus Biosciences Inc | 2025-03-31 | Add Add | +0.84% | 7.85 ($11.59) 15.24 | $9.40 | -18.90% | Add 145.9% | 625,126 | 370,909 | |
ASND | Ascendis Pharma AS | 2025-03-31 | Reduce Reduce | -0.81% | 119.49 ($142.85) 168.84 | $168.85 | 18.20% | Reduce -22.21% | 80,398 | -22,957 | |
MLYS | Mineralys Therapeutics Inc | 2025-03-31 | Add Add | +0.74% | 8.76 ($11.5) 16.87 | $14.30 | 24.39% | Add 111.06% | 309,200 | 162,700 | |
AXGN | Axogen Inc | 2025-03-31 | Reduce Reduce | -0.70% | 14.56 ($18.05) 20.11 | $11.58 | -35.84% | Reduce -19.61% | 680,782 | -166,100 | |
STOK | Stoke Therapeutics Inc | 2025-03-31 | Add Add | +0.52% | 6.65 ($9.32) 12.74 | $12.85 | 37.88% | Add 159.5% | 443,998 | 272,901 | |
INGN | Inogen Inc | 2025-03-31 | Add Add | +0.51% | 6.8 ($9.43) 12.53 | $6.43 | -31.81% | Add 119.39% | 458,065 | 249,275 | |
DNLI | Denali Therapeutics Inc | 2025-03-31 | New Buy New Buy | +0.50% | 13.6 ($19.16) 23.59 | $14.22 | -25.78% | New holding | 127,900 | 127,900 | |
IDYA | IDEAYA Biosciences Inc | 2025-03-31 | Add Add | +0.43% | 16.38 ($21.31) 26 | $22.22 | 4.27% | Add 18.14% | 589,330 | 90,503 | |
BCAX | Bicara Therapeutics Inc | 2025-03-31 | Add Add | +0.40% | 11.61 ($13.28) 16.93 | $11.16 | -15.93% | Add 100.95% | 212,001 | 106,501 | |
ATRC | AtriCure Inc | 2025-03-31 | Reduce Reduce | -0.39% | 30.4 ($37.12) 42.4 | $29.67 | -20.07% | Reduce -7.7% | 592,273 | -49,400 |
DAFNA Capital Management LLC Total Holding History ($B)
DAFNA Capital Management LLC's Asset Allocation
DAFNA Capital Management LLC Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
DAFNA Capital Management LLC's Hypothetical Growth since 2025-03-31
DAFNA Capital Management LLC's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
DAFNA Capital Management LLC's Holdings Heat Map
Size field:
DAFNA Capital Management LLC's Holdings Bubble Chart
DAFNA Capital Management LLC News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers